Swept-source optical coherence tomography identifies the morphological features implicated in the underlying physiopathological mechanisms of chronic central serous chorioretinopathy, researchers report.
Month: May 2014
Genetic susceptibility, dietary antioxidants combine to reduce AMD risk
Dietary intake of antioxidants is associated with a reduced risk of developing early age-related macular degeneration in people at high genetic risk of the condition, pooled analysis of two studies suggests.
Support for internal limiting membrane peeling for full-thickness macular holes
Vitrectomy with peeling of the internal limiting membrane of the retina improves the outcome of idiopathic full-thickness macular hole surgery compared with no peeling, study findings show.
Retinal measurements associated with Parkinson’s disease duration
The inner retinal layers in the eyes of patients with Parkinson’s disease are thinner than those of healthy people’s eyes, except for the inner nuclear layer, which is thicker, show the results of a prospective study involving the latest optical coherence tomography methods.
Single treatment for AMD ‘unlikely’
Age-related macular degeneration does not follow the same disease course from one patient to another, conclude researchers who suggest that phenotyping may be important before initiating a therapeutic trial.
Patching, Drops Improve Vision Over Long Term in Amblyopia
Either patching or atropine eye drops improved vision in a long-term follow-up of the Pediatric Eye Disease Investigator Group RCT in children with amblyopia. Medscape Medical News
LPI in temporal iris yields less linear dysphotopsia than in superior iris
Laser peripheral iridotomy performed in the temporal iris resulted in less linear dysphotopsia than in the superior iris, according to a study. The prospective, randomized clinical trial included 338 eyes of 169 patients with primary angle-closure glau…
Many Americans unaware of photosensitivity due to light-colored eyes, common drugs
Many Americans with light-colored eyes and those who take common drugs are unaware they are more vulnerable to UV exposure, which can be a factor in some eye conditions and diseases, according to the results of a poll released by the American Academy o…
Alphaeon names Bob Rhatigan chief operating officer
Bob Rhatigan has joined Alphaeon as its chief operating officer, the company announced in a news release. In his position as COO, Rhatigan will play a prominent role in the development of Alphaeon’s commercial execution and future growth. “Bob has an outstanding track record of successful business leadership in medical aesthetics and will add tremendous value as Alphaeon continues its rapid expansion to become the leader in providing innovative products and services in the lifestyle health care market,” Robert E. Grant, CEO of Alphaeon, said in the release.
VIDEO: Laser safely treats front and back of the eye
A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects
Status: Completed,
Condition Summary: Glaucoma; Ocular Hypertension; Eye Disease